Risk prediction model establishment with tri-phasic CT image features for differential diagnosis of adrenal pheochromocytomas and lipid-poor adenomas: Grouping method

Front Endocrinol (Lausanne). 2022 Dec 8:13:925577. doi: 10.3389/fendo.2022.925577. eCollection 2022.

Abstract

Objectives: The purpose of this study was to establish a risk prediction model for differential diagnosis of pheochromocytomas (PCCs) from lipid-poor adenomas (LPAs) using a grouping method based on tri-phasic CT image features.

Methods: In this retrospective study, we enrolled patients that were assigned to a training set (136 PCCs and 183 LPAs) from two medical centers, along with an external independent validation set (30 PCCs and 54 LPAs) from another center. According to the attenuation values in unenhanced CT (CTu), the lesions were divided into three groups: group 1, 10 HU < CTu ≤ 25 HU; group 2, 25 HU < CTu ≤ 40 HU; and group 3, CTu > 40 HU. Quantitative and qualitative CT imaging features were calculated and evaluated. Univariate, ROC, and binary logistic regression analyses were applied to compare these features.

Results: Cystic degeneration, CTu, and the peak value of enhancement in the arterial and venous phase (DEpeak) were independent risk factors for differential diagnosis of adrenal PCCs from LPAs. In all subjects (groups 1, 2, and 3), the model formula for the differentiation of PCCs was as follows: Y = -7.709 + 3.617*(cystic degeneration) + 0.175*(CTu ≥ 35.55 HU) + 0.068*(DEpeak ≥ 51.35 HU). ROC curves were drawn with an AUC of 0.95 (95% CI: 0.927-0.973) in the training set and 0.91 (95% CI: 0.860-0.929) in the external validation set.

Conclusion: A reliable and practical prediction model for differential diagnosis of adrenal PCCs and LPAs was established using a grouping method.

Keywords: adenomas; adrenal; computed tomography; pheochromocytomas; risk prediction model.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoma* / diagnostic imaging
  • Adenoma* / pathology
  • Adrenal Gland Neoplasms* / diagnostic imaging
  • Adrenal Gland Neoplasms* / pathology
  • Diagnosis, Differential
  • Humans
  • Lipids
  • Pheochromocytoma* / diagnostic imaging
  • Retrospective Studies
  • Sensitivity and Specificity
  • Tomography, X-Ray Computed / methods

Substances

  • Lipids